Startups
AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.
Summary
21
Industry
Total funding Amount
$3.2M
Fundraising History
-
Apr 01 '22 Unknown$3.2M
Investors
-
Ascension VenturesUnknown
-
Future Planet CapitalUnknown
-
Northstar VenturesUnknown